《中国耳鼻咽喉头颈外科》伴随头颈外科发展

《中国耳鼻咽喉头颈外科》创刊十年了。本文概述了伴随头颈外科发展的《中国耳鼻咽喉头颈外科》杂志的成长历程，显示其不断发展和与时俱进的风貌。     

2006年全国耳鼻咽喉头颈外科科主任管理培训纪要

2006年10月27-29日，由中华医学会耳鼻咽喉科学分会和中华耳鼻咽喉头颈外科杂志编委会主办，中美天津史克制药有限公司协办的“全国耳鼻咽喉头颈外科科主任管理培训”在河北香河天下第一城会议中心开幕（图1）。     

全国头颈肿瘤外科新进展学习班通知

由上海复旦大学眼耳鼻喉科医院耳鼻咽喉-头颈外科周梁教授主办、南昌大学第一附属医院耳鼻咽喉-头颈外科协办的国家级继续教育项目“全国头颈肿瘤外科新进展学习班”拟定于2006年7月5日～8日在江西省九江市庐山举行。     

全国甲状腺肿瘤外科治疗专题学术会议在济南成功举办

2011年4月23～26日,由中华医学会耳鼻咽喉头颈外科分会头颈组、中国抗癌协会头颈肿瘤专业委员会、中华耳鼻咽喉头颈外科杂志编委会、中华外科杂志编委会联合     

继承与发展--祝贺本刊更名为《中华耳鼻咽喉头颈外科杂志》

《中华耳鼻咽喉科杂志》作为中华医学会主办的耳鼻咽喉科学专业学术期刊 ,承载着全国耳鼻咽喉科界同行的智慧和期望 ,凝聚了几代人的心血与辛劳 ,已走过了半个多世纪的历程。 5 0多年来 ,随着耳鼻咽喉专业在广度和深度上的进展 ,本刊紧跟国际潮流 ,及时反映我国耳鼻咽喉发展的最新成就 ,引导专业水平不断走向新的高度。近 2 0年来 ,不少前贤为学科外延和内涵的发展 ,为专科学会和杂志的正名以促进发展 ,做出了不懈努力。在新世纪的第5个年头 ,经过中华医学会、中国科学技术协会、新闻出版总署逐级审批 ,本刊终于以《中华耳鼻咽喉头颈外科杂…     

2014全国耳鼻咽喉头颈外科新进展研讨会隆重举行

由上海市第一人民医院耳鼻咽喉头颈外科举办的2014全国耳鼻咽喉科新技术新进展研讨会、第十四届全国咽喉头颈肿瘤综合治疗新进展学习班及首届长三角耳鼻咽喉头颈外科论坛于2014年5月21-24日隆重召开。     

迎接中国耳鼻咽喉头颈外科发展新阶段

《耳鼻咽喉-头颈外科》杂志的十年发展，见证了中国耳鼻咽喉头颈外科学科发展近年来所走过的历程。本文回顾了耳鼻咽喉头颈外科学科成长的历史，展示了学科在若干领域内取得的骄人进展，并对今后学科的发展提出了建设性的建议。     

2004年中华医学会湖南分会耳鼻咽喉-头颈外科专业学术年会在长沙举行

中华医学会湖南分会耳鼻咽喉-头颈外科学术年会于2004年6月19～22日在长沙举行。本次会议共收论文126篇，其中耳科学30篇，鼻科学34篇，咽喉气管食管学31篇，头颈学18篇，专题讲座13篇。参加会议代表150余人。论文内容丰富，基本上反映了湖南省同道在该领域的学术水平及研究进展。会上肖健云、卢永德、赵素萍、任基浩、冯永教授作了专题发言。     

Palliative chemotherapy of head and neck cancer: present status and future development

BACKGROUND: Patients with head and neck tumors are treated with palliative chemotherapy in case of the detection of distant metastases or local recurrence without the option of surgical therapy or radiation. Alongside 5-fluorouracil (5-FU) in combination with cisplatin or carboplatin, taxanes, gemcitabine and vinorelbine as well as monoclonal antibodies or small molecule tyrosine kinase inhibitors have been used. METHODS: This review analyses the published literature of the past 15 years, including selected abstracts with view to response rate, overall survival and adverse effects. RESULTS: 5-FU plus cisplatin or carboplatin can still be considered as standard treatment, achieving response rates of 20-30 %. The addition of taxanes increases the objective response rate but adds remarkable toxicity to the treatment protocol. Phase III studies demonstrate higher response rates but fail to demonstrate a significant increase of the overall survival after polychemotherapy as compared to monotherapy protocols. Thus, patients with a reduced performance can be treated with monotherapy. In case of disease progression after cisplatin-containing chemotherapy further treatment should only be offered to selected patients. For this situation, platin-free chemotherapy protocols containing taxanes, gemcitabine or vinorelbine seem promising. Recent studies with monoclonal antibodies or small molecule tyrosine kinase inhibitors report on a response rate of 10-20 %. CONCLUSION: The use of new drugs increases the response rate and amends the side effects of the chemotherapy. However, phase III studies documenting an improved overall survival are lacking. Targeted therapies broaden the therapeutic armament, and possibly, EGFR inhibition will help to overcome chemotherapy resistance in the future.     

加速康复外科在耳鼻咽喉头颈外科的现状和发展

加速康复外科（enhanced recovery after surgery,ERAS）因其能促进患者术后快速康复,减少围手术期并发症以及良好的卫生经济学效益,具有广阔的临床应用前景。但ERAS在耳鼻咽喉头颈外科的实践起步较晚,尚缺乏系统的、推广性强的指南和管理方法,应用受到制约。本文从概括ERAS在围手术期各阶段的应...     

Same-day-stay head and neck surgery

The purpose of this study was to determine if selective head and neck surgical procedures on a same-day basis are justifiable. Two hundred consecutive head and neck same-day procedures were reviewed, including 84 parotidectomies and 116 other procedures previously managed as inpatients. Of the 200 patients, 36 (18%) were admitted, 33 for overnight observation, and 164 (82%) were discharged the same day. There were no complications reported in the discharged patients and a later questionnaire showed that 97% of the patients were satisfied. The advantages of selective same-day procedures outweigh the disadvantages for otolaryngologist and patient. The study shows that same-day-stay head and neck surgery for selective procedures is safe, reasonable, and cost-effective, but the combined efforts of the otolaryngologists, nurses, and administrators are required. Because of rising healthcare costs, experts are predicting a significant increase in the next few years of outpatient surgery, including surgery of the head and neck.     

Hypothermia during head and neck surgery

OBJECTIVE: To determine the predictors and incidence of hypothermia in patients undergoing head and neck surgery. STUDY DESIGN: Retrospective analysis. METHODS: Patients were either not warmed (n = 43) or actively warmed with forced-air warming (n = 25). Clinical variables that were assessed as predictors of core body temperature included age, body mass, duration of procedure, estimated blood loss, amount of intravenous fluids administered, and the use of forced-air warming. The incidence of severe intraoperative hypothermia and potential hypothermia-related complications was also examined. RESULTS: The study demonstrated that advanced age is a risk factor for hypothermia and decreased body mass is associated with lower final body temperatures in the groups of patients that was not warmed. After adjusting for differences in the ages and weights between the two groups, the mean core body temperature was found to be 0.4 degrees C lower in the patients who were not warmed. Severe intraoperative hypothermia occurred in 5 of 38 patients (11.6%) who were not warmed and 2 of 23 patients (8.0%) who were warmed. The complications associated with hypothermia included delayed time to extubation, the development of neck seromas, and flap dehiscence. CONCLUSIONS: Patients undergoing head and neck surgery are at risk for the development of intraoperative hypothermia and require careful temperature monitoring. Elderly patients and patients with low body mass are more prone to develop low intraoperative core body temperatures. Active warming with forced-air warmers should be considered for patients at risk for intraoperative hypothermia and for patients who develop hypothermia intraoperatively, to avoid hypothermia-related complications.